521 related articles for article (PubMed ID: 32392952)
21. [A multicenter study on the surfactant treatment in late-preterm or term infants with respiratory distress syndrome].
Collaborative Study Group for Late-preterm/Term Infants with Respiratory Distress
Zhonghua Er Ke Za Zhi; 2014 Oct; 52(10):724-8. PubMed ID: 25537535
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study.
Jeon GW; Oh M; Sin JB
Yonsei Med J; 2015 Mar; 56(2):433-9. PubMed ID: 25683992
[TBL] [Abstract][Full Text] [Related]
23. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.
Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H
Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of intratracheal administration of budesonide combined with pulmonary surfactant in preventing bronchopulmonary dysplasia: a prospective randomized controlled trial.
Liu MM; Ji L; Dong MY; Zhu XF; Wang HJ
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Jan; 24(1):78-84. PubMed ID: 35177180
[TBL] [Abstract][Full Text] [Related]
25. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
[TBL] [Abstract][Full Text] [Related]
26. The impact of combined administration of surfactant and intratracheal budesonide compared to surfactant alone on bronchopulmonary dysplasia (BPD) and mortality rate in preterm infants with respiratory distress syndrome: a single-blind randomized clinical trial.
Marzban A; Mokhtari S; Tavakkolian P; Mansouri R; Jafari N; Maleki A
BMC Pediatr; 2024 Apr; 24(1):262. PubMed ID: 38643076
[TBL] [Abstract][Full Text] [Related]
27. Early treatment of respiratory distress syndrome with bovine surfactant in very preterm infants: a multicenter controlled clinical trial.
Gortner L; Bartmann P; Pohlandt F; Bernsau U; Porz F; Hellwege HH; Seitz RC; Hieronimi G; Bremer C; Jorch G
Pediatr Pulmonol; 1992 Sep; 14(1):4-9. PubMed ID: 1437342
[TBL] [Abstract][Full Text] [Related]
28. Surfactant therapy in premature babies: SurE or InSurE.
Jena SR; Bains HS; Pandita A; Verma A; Gupta V; Kallem VR; Abdullah M; Kawdiya A; On Behalf Of Sure Group
Pediatr Pulmonol; 2019 Nov; 54(11):1747-1752. PubMed ID: 31424177
[TBL] [Abstract][Full Text] [Related]
29. Early respiratory management of respiratory distress syndrome in very preterm infants and bronchopulmonary dysplasia: a case-control study.
Te Pas AB; Lopriore E; Engbers MJ; Walther FJ
PLoS One; 2007 Feb; 2(2):e192. PubMed ID: 17285145
[TBL] [Abstract][Full Text] [Related]
30. [Risk factors and short-term prognosis of early pulmonary hypertension in preterm infants].
Wang CH; Chen JJ; Ge JJ; Ma XL; Shi LP
Zhonghua Er Ke Za Zhi; 2022 Jul; 60(7):682-687. PubMed ID: 35768356
[No Abstract] [Full Text] [Related]
31. [Establishment and efficiency test of a clinical prediction model of bronchopulmonary dysplasia associated pulmonary hypertension in very premature infants].
Cao JK; Fan HQ; Xiao YB; Wang D; Liu CG; Peng XM; Gao XR; Tang SH; Han T; Mei YB; Liang HY; Wang SM; Wang F; Li QP
Zhonghua Er Ke Za Zhi; 2024 Feb; 62(2):129-137. PubMed ID: 38264812
[No Abstract] [Full Text] [Related]
32. Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age: A Randomized Clinical Trial.
Hascoët JM; Picaud JC; Ligi I; Blanc T; Moreau F; Pinturier MF; Zupan V; Guilhoto I; Hamon IR; Alexandre C; Bouissou A; Storme L; Patkai J; Pomedio M; Rouabah M; Coletto L; Vieux R
JAMA Pediatr; 2016 Apr; 170(4):365-72. PubMed ID: 26928567
[TBL] [Abstract][Full Text] [Related]
33. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
[TBL] [Abstract][Full Text] [Related]
34. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants.
Moya FR; Gadzinowski J; Bancalari E; Salinas V; Kopelman B; Bancalari A; Kornacka MK; Merritt TA; Segal R; Schaber CJ; Tsai H; Massaro J; d'Agostino R;
Pediatrics; 2005 Apr; 115(4):1018-29. PubMed ID: 15805380
[TBL] [Abstract][Full Text] [Related]
35. Surfactant utilization and short-term outcomes in an era of non-invasive respiratory support in Canadian neonatal intensive care units.
Raghuram K; Mukerji A; Young J; Yee W; Seshia M; Dow K; Shah V
J Perinatol; 2017 Sep; 37(9):1017-1023. PubMed ID: 28661515
[TBL] [Abstract][Full Text] [Related]
36. Respiratory distress syndrome in preterm infants of less than 32 weeks: What difference does giving 100 or 200 mg/kg of exogenous surfactant make?
Lanciotti L; Correani A; Pasqualini M; Antognoli L; Dell'Orto VG; Giorgetti C; Colombo S; Palazzi ML; Rondina C; Burattini I; Carnielli VP
Pediatr Pulmonol; 2022 Sep; 57(9):2067-2073. PubMed ID: 35577766
[TBL] [Abstract][Full Text] [Related]
37. Non-invasive duo positive airway pressure ventilation versus nasal continuous positive airway pressure in preterm infants with respiratory distress syndrome: a randomized controlled trial.
Malakian A; Aramesh MR; Agahin M; Dehdashtian M
BMC Pediatr; 2021 Jul; 21(1):301. PubMed ID: 34229655
[TBL] [Abstract][Full Text] [Related]
38. The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25-28 weeks gestation.
Dargaville PA; Kamlin CO; De Paoli AG; Carlin JB; Orsini F; Soll RF; Davis PG
BMC Pediatr; 2014 Aug; 14():213. PubMed ID: 25164872
[TBL] [Abstract][Full Text] [Related]
39. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants.
Soll RF; Morley CJ
Cochrane Database Syst Rev; 2001; (2):CD000510. PubMed ID: 11405966
[TBL] [Abstract][Full Text] [Related]
40. Minimally invasive surfactant administration in preterm infants: a meta-narrative review.
More K; Sakhuja P; Shah PS
JAMA Pediatr; 2014 Oct; 168(10):901-8. PubMed ID: 25089718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
